Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

E. Havrdova, S. Galetta, M. Hutchinson, D. Stefoski, D. Bates, C.H. Polman, P.W. O'Connor, G. Giovannoni, J.T. Phillips, F.D. Lublin, A. Pace, R. Kim, R. Hyde

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)254-260
JournalLancet Neurology
Issue number3
Publication statusPublished - 2009

Cite this